Registro:

Referencias:

• Acosta, J.C., O’Loghlen, A., Banito, A., Guijarro, M.V., Augert, A., Raguz, S., Fumagalli, M., Popov, N., Chemokine signaling via the CXCR2 receptor reinforces senescence (2008) Cell, 133, pp. 1006-1018
• Alexandraki, K.I., Munayem Khan, M., Chahal, H.S., Dalantaeva, N.S., Trivellin, G., Berney, D.M., Caron, P., Jordan, S., Oncogene-induced senescence in pituitary adenomas and carcinomas (2012) Hormones, 11, pp. 297-307
• Ancrile, B., Lim, K.H., Counter, C.M., Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis (2007) Genes and Development, 21, pp. 1714-1719
• Andoniadou, C.L., Matsushima, D., Mousavy Gharavy, S.N., Signore, M., Mackintosh, A.I., Schaeffer, M., Gaston-Massuet, C., Le Tissier, P., Sox2(+) stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential (2013) Cell Stem Cell, 13, pp. 433-445
• Andus, T., Geiger, T., Hirano, T., Northoff, H., Ganter, U., Bauer, J., Kishimoto, T., Heinrich, P.C., Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells (1987) FEBS Letters, 221, pp. 18-22
• Arzt, E., Gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuro-endocrine pathways (2001) Journal of Clinical Investigation, 108, pp. 1729-1733
• Arzt, E., Buric, R., Stelzer, G., Stalla, J., Sauer, J., Renner, U., Stalla, G.K., Interleukin involvement in anterior pituitary cell growth regulation: Effects of IL-2 and IL-6 (1993) Endocrinology, 132, pp. 459-467
• Arzt, E., Pereda, M.P., Castro, C.P., Pagotto, U., Renner, U., Stalla, G.K., Pathophysiological role of the cytokine network in the anterior pituitary gland (1999) Frontiers in Neuroendocrinology, 20, pp. 71-95
• Arzt, E., Chesnokova, V., Stalla, G.K., Melmed, S., Pituitary adenoma growth: A model for cellular senescence and cytokine action (2009) Cell Cycle, 8, pp. 677-678
• Baker, D.J., Sedivy, J.M., Probing the depths of cellular senescence (2013) Journal of Cell Biology, 202, pp. 11-13
• Barrett, E., Brothers, S., Wahlestedt, C., Beurel, E., I-BET151 selectively regulates IL-6 production (2014) Biochimica Et Biophysica Acta, 1842, pp. 1549-1555
• Bethin, K.E., Vogt, S.K., Muglia, L.J., Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation (2000) PNAS, 97, pp. 9317-9322
• Borg, S.A., Kerry, K.E., Baxter, L., Royds, J.A., Jones, T.H., Expression of interleukin-6 and its effects on growth of HP75 human pituitary tumor cells (2003) Journal of Clinical Endocrinology and Metabolism, 88, pp. 4938-4944
• Bowman, T., Garcia, R., Turkson, J., Jove, R., STATs in oncogenesis (2000) Oncogene, 19, pp. 2474-2488
• Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A.H., Schlegelberger, B., Stein, H., Schmitt, C.A., Oncogene-induced senescence as an initial barrier in lymphoma development (2005) Nature, 436, pp. 660-665
• Castro, C.P., Giacomini, D., Nagashima, A.C., Onofri, C., Graciarena, M., Kobayashi, K., Paez-Pereda, M., Arzt, E., Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells (2003) Endocrinology, 144, pp. 693-700
• Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., Scheller, J., The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer (2011) European Journal of Cell Biology, 90, pp. 484-494
• Chen, Z., Trotman, L.C., Shaffer, D., Lin, H.K., Dotan, Z.A., Niki, M., Koutcher, J.A., Gerald, W., Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis (2005) Nature, 436, pp. 725-730
• Chesnokova, V., Kovacs, K., Castro, A.V., Zonis, S., Melmed, S., Pituitary hypoplasia in Pttg-/-mice is protective for Rb+/-pituitary tumorigenesis (2005) Molecular Endocrinology, 19, pp. 2371-2379
• Chesnokova, V., Zonis, S., Rubinek, T., Yu, R., Ben-Shlomo, A., Kovacs, K., Wawrowsky, K., Melmed, S., Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth (2007) Cancer Research, 67, pp. 10564-10572
• Chesnokova, V., Zonis, S., Kovacs, K., Ben-Shlomo, A., Wawrowsky, K., Bannykh S & Melmed S 2008 p21(Cip1) restrains pituitary tumor growth PNAS, 105, pp. 17498-17503
• Chesnokova, V., Zonis, S., Zhou, C., Ben-Shlomo, A., Wawrowsky, K., Toledano, Y., Tong, Y., Melmed, S., Lineage-specific restraint of pituitary gonadotroph cell adenoma growth (2011) Plos ONE, 6
• Cichowski, K., Hahn, W.C., Unexpected pieces to the senescence puzzle (2008) Cell, 133, pp. 958-961
• Clayton, R.N., Farrell, W.E., Pituitary tumour clonality revisited (2004) Frontiers of Hormone Research, 32, pp. 186-204
• Colao, A., Ochoa, A.S., Auriemma, R.S., Faggiano, A., Pivonello, R., Lombardi, G., Pituitary carcinomas (2010) Frontiers of Hormone Research, 38, pp. 94-108
• Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A.J., Barradas, M., Benguria, A., Barbacid, M., Tumour biology: Senescence in premalignant tumours (2005) Nature, 436, p. 642
• Coppe, J.P., Patil, C.K., Rodier, F., Sun, Y., Munoz, D.P., Goldstein, J., Nelson, P.S., Campisi, J., Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor (2008) Plos Biology, 6, pp. 2853-2868
• Coppe, J.P., Boysen, M., Sun, C.H., Wong, B.J., Kang, M.K., Park, N.H., Desprez, P.Y., Krtolica, A., A role for fibroblasts in mediating the effects of tobacco-induced epithelial cell growth and invasion (2008) Molecular Cancer Research, 6, pp. 1085-1098
• Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: The dark side of tumor suppression (2010) Annual Review of Pathology, 5, pp. 99-118
• Courtois-Cox, S., Genther Williams, S.M., Reczek, E.E., Johnson, B.W., McGillicuddy, L.T., Johannessen, C.M., Hollstein, P.E., Cichowski, K., A negative feedback signaling network underlies oncogene-induced senescence (2006) Cancer Cell, 10, pp. 459-472
• D’Adda Di Fagagna, F., Living on a break: Cellular senescence as a DNA-damage response (2008) Nature Reviews Cancer, 8, pp. 512-522
• Darnell, J.E., Jr., STATs and gene regulation (1997) Science, 277, pp. 1630-1635
• Dinarello, C.A., Historical insights into cytokines (2007) European Journal of Immunology, 37, pp. S34-S45
• Donangelo, I., Gutman, S., Horvath, E., Kovacs, K., Wawrowsky, K., Mount, M., Melmed, S., Pituitary tumor transforming gene overexpression facilitates pituitary tumor development (2006) Endocrinology, 147, pp. 4781-4791
• Donangelo, I., Ren, S.G., Eigler, T., Svendsen, C., Melmed, S., Sca1(+) murine pituitary adenoma cells show tumor-growth advantage (2014) Endocrine-Related Cancer, 21, pp. 203-216
• Dou, L., Zhao, T., Wang, L., Huang, X., Jiao, J., Gao, D., Zhang, H., Wang, S., 2013 miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes Journal of Biological Chemistry, 288, pp. 22596-22606
• Dranoff, G., Cytokines in cancer pathogenesis and cancer therapy (2004) Nature Reviews Cancer, 4, pp. 11-22
• Dworakowska, D., Grossman, A.B., The pathophysiology of pituitary adenomas (2009) Best Practice and Research Clinical Endocrinology and Metabolism, 23, pp. 525-541
• Dworakowska, D., Grossman, A.B., The molecular pathogenesis of pituitary tumors: Implications for clinical management (2012) Minerva Endocrinologica, 37, pp. 157-172
• Farnoud, M.R., Kujas, M., Derome, P., Racadot, J., Peillon, F., Li, J.Y., Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas. An immunohistochemical study (1994) Virchows Archiv, 424, pp. 75-82
• Farrell, W.E., Pituitary tumours: Findings from whole genome analyses (2006) Endocrine-Related Cancer, 13, pp. 707-716
• Farrell, W.E., Clayton, R.N., Molecular genetics of pituitary tumours (1998) Trends in Endocrinology and Metabolism, 9, pp. 20-26
• Fauquier, T., Rizzoti, K., Dattani, M., Lovell-Badge, R., Robinson, I.C., SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland (2008) PNAS, 105, pp. 2907-2912
• Florio, T., Adult pituitary stem cells: From pituitary plasticity to adenoma development (2011) Neuroendocrinology, 94, pp. 265-277
• Garcia-Lavandeira, M., Quereda, V., Flores, I., Saez, C., Diaz-Rodriguez, E., Japon, M.A., Ryan, A.K., Malumbres, M., A GRFa2/Prop1/stem (GPS) cell niche in the pituitary (2009) Plos ONE, 4
• Garcia-Lavandeira, M., Diaz-Rodriguez, E., Bahar, D., Garcia-Rendueles, A.R., Rodrigues, J.S., Dieguez, C., Alvarez, C.V., Pituitary cell turnover: From adult stem cell recruitment through differentiation to death (2015) Neuroendocrinology, 101, pp. 175-192
• Garg, M., Potter, J.A., Abrahams, V.M., Identification of microRNAs that regulate TLR2-mediated trophoblast apoptosis and inhibition of IL-6 mRNA (2013) Plos ONE, 8
• Gaston-Massuet, C., Oniadou, C.L., Signore, M., Jayakody, S.A., Charolidi, N., Kyeyune, R., Vernay, B., Le Tissier, P., Increased Wingless (Wnt) signaling in pituitary progenitor/ stem cells gives rise to pituitary tumors in mice and humans (2011) PNAS, 108, pp. 11482-11487
• Gerlo, S., Haegeman, G., Vanden Berghe, W., Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells (2008) Cellular Signalling, 20, pp. 1489-1496
• Gleiberman, A.S., Michurina, T., Encinas, J.M., Roig, J.L., Krasnov, P., Balordi, F., Fishell, G., Enikolopov, G., Genetic approaches identify adult pituitary stem cells (2008) PNAS, 105, pp. 6332-6337
• Gloddek, J., Pagotto, U., Paez Pereda, M., Arzt, E., Stalla, G.K., Renner, U., Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells (1999) Journal of Endocrinology, 160, pp. 483-490
• Goel, V.K., Ibrahim, N., Jiang, G., Singhal, M., Fee, S., Flotte, T., Westmoreland, S., Haluska, F.G., Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice (2009) Oncogene, 28, pp. 2289-2298
• Graciarena, M., Carbia-Nagashima, A., Onofri, C., Perez-Castro, C., Giacomini, D., Renner, U., Stalla, G.K., Arzt, E., Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model (2004) European Journal of Endocrinology, 151, pp. 595-604
• Green, M.R., Senescence: Not just for tumor suppression (2008) Cell, 134, pp. 562-564
• Gruys, E., Toussaint, M.J., Niewold, T.A., Koopmans, S.J., Acute phase reaction and acute phase proteins (2005) Journal of Zheijang University Science B, 6, pp. 1045-1056
• Hanisch, A., Dieterich, K.D., Dietzmann, K., Ludecke, K., Buchfelder, M., Fahlbusch, R., Lehnert, H., Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 4411-4414
• He, Y., Sun, X., Huang, C., Long, X.R., Lin, X., Zhang, L., Lv, X.W., Li, J., MiR-146a regulates IL-6 production in lipopolysaccharide-induced RAW264.7 macrophage cells by inhibiting Notch1 (2014) Inflammation, 37, pp. 71-82
• Heinrich, P.C., Behrmann, I., Haan, S., Hermanns, H.M., Muller-Newen, G., Schaper, F., Principles of interleukin (IL)-6-type cytokine signalling and its regulation (2003) Biochemical Journal, 374, pp. 1-20
• Hirano, T., Revisiting the 1986 molecular cloning of interleukin 6 (2014) Frontiers in Immunology, 5, p. 456
• Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Iwamatsu, A., Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin (1986) Nature, 324, pp. 73-76
• Hirano, T., Nakajima, K., Hibi, M., Signaling mechanisms through gp130: A model of the cytokine system (1997) Cytokine and Growth Factor Reviews, 8, pp. 241-252
• Hirano, T., Ishihara, K., Hibi, M., Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors (2000) Oncogene, 19, pp. 2548-2556
• Hodes, G.E., Pfau, M.L., Leboeuf, M., Golden, S.A., Christoffel, D.J., Bregman, D., Rebusi, N., Warren, B.L., Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress (2014) PNAS, 111, pp. 16136-16141
• Hofler, H., Walter, G.F., Denk, H., Immunohistochemistry of folliculo-stellate cells in normal human adenohypophyses and in pituitary adenomas (1984) Acta Neuropathologica, 65, pp. 35-40
• Hosoyama, T., Nishijo, K., Garcia, M.M., Schaffer, B.S., Ohshima-Hosoyama, S., Prajapati, S.I., Davis, M.D., Marks, D.L., A postnatal Pax7 progenitor gives rise to pituitary adenomas (2010) Genes and Cancer, 1, pp. 388-402
• Hunter, C.A., Jones, S.A., IL-6 as a keystone cytokine in health and disease (2015) Nature Immunology, 16, pp. 448-457
• Iwasaki, H., Takeuchi, O., Teraguchi, S., Matsushita, K., Uehata, T., Kuniyoshi, K., Satoh, T., Standley, D.M., The IkappaB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1 (2011) Nature Immunology, 12, pp. 1167-1175
• Jiang, X., Zhang, X., The molecular pathogenesis of pituitary adenomas: An update (2013) Endocrinology and Metabolism, 28, pp. 245-254
• Jones, T.H., Daniels, M., James, R.A., Justice, S.K., McCorkle, R., Price, A., Kendall-Taylor, P., Weetman, A.P., Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas (1994) Journal of Clinical Endocrinology and Metabolism, 78, pp. 180-187
• Jones, S.A., Horiuchi, S., Topley, N., Yamamoto, N., Fuller, G.M., The soluble interleukin 6 receptor: Mechanisms of production and implications in disease (2001) FASEB Journal, 15, pp. 43-58
• Jones, S.A., Scheller, J., Rose-John, S., Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling (2011) Journal of Clinical Investigation, 121, pp. 3375-3383
• Kim, D., Pemberton, H., Stratford, A.L., Buelaert, K., Watkinson, J.C., Lopes, V., Franklyn, J.A., McCabe, C.J., Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells (2005) Oncogene, 24, pp. 4861-4866
• Kim, D.S., Franklyn, J.A., Smith, V.E., Stratford, A.L., Pemberton, H.N., Warfield, A., Watkinson, J.C., McCabe, C.J., Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity (2007) Carcinogenesis, 28, pp. 749-759
• Kishimoto, T., Interleukin-6: From basic science to medicine-40 years in immunology (2005) Annual Review of Immunology, 23, pp. 1-21
• Klimpel, G.R., Soluble factor(S) from LPS-activated macrophages induce cytotoxic T cell differentiation from alloantigen-primed spleen cells (1980) Journal of Immunology, 125, pp. 1243-1249
• Kojima, H., Inoue, T., Kunimoto, H., Nakajima, K., IL-6-STAT3 signaling and premature senescence (2013) JAK-STAT, 2
• Kopczak, A., Renner, U., Karl Stalla, G., Advances in understanding pituitary tumors (2014) F1000prime Reports, 6, p. 5
• Kovacs, E., Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients (2001) Biomedicine and Pharmacotherapy, 55, pp. 391-396
• Kraakman, M.J., Kammoun, H.L., Allen, T.L., Deswaerte, V., Henstridge, D.C., Estevez, E., Matthews, V.B., Murphy, A.J., Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance (2015) Cell Metabolism, 21, pp. 403-416
• Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.Y., Campisi, J., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging (2001) PNAS, 98, pp. 12072-12077
• Kuilman, T., Peeper, D.S., Senescence-messaging secretome: SMS-ing cellular stress (2009) Nature Reviews Cancer, 9, pp. 81-94
• Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., van Doorn, R., Desmet, C.J., Aarden, L.A., Peeper, D.S., Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network (2008) Cell, 133, pp. 1019-1031
• Kumari, N., Dwarakanath, B.S., Das, A., Bhatt, A.N., Role of interleukin-6 in cancer progression and therapeutic resistance (2016) Tumour Biology, 37, pp. 11553-11572
• Lake, M.G., Krook, L.S., Cruz, S.V., Pituitary adenomas: An overview (2013) American Family Physician, 88, pp. 319-327
• Lazzerini Denchi, E., Helin, K., E2F1 is crucial for E2F-dependent apoptosis (2005) EMBO Reports, 6, pp. 661-668
• Lecot, P., Alimirah, F., Desprez, P.Y., Campisi, J., Wiley, C., Context-dependent effects of cellular senescence in cancer development (2016) British Journal of Cancer, 114, pp. 1180-1184
• Lee, K.A., Hai, T.Y., Sivaraman, L., Thimmappaya, B., Hurst, H.C., Jones, N.C., Green, M.R., A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters (1987) PNAS, 84, pp. 8355-8359
• Lehmann, U., Schmitz, J., Weissenbach, M., Sobota, R.M., Hortner, M., Friederichs, K., Behrmann, I., Schneider-Mergener, J., SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130 (2003) Journal of Biological Chemistry, 278, pp. 661-671
• Levy, A., Lightman, S., Molecular defects in the pathogenesis of pituitary tumours (2003) Frontiers in Neuroendocrinology, 24, pp. 94-127
• Liu, B., Liao, J., Rao, X., Kushner, S.A., Chung, C.D., Chang, D.D., Shuai, K., Inhibition of Stat1-mediated gene activation by PIAS1 (1998) PNAS, 95, pp. 10626-10631
• Masuda, K., Ripley, B., Nishimura, R., Mino, T., Takeuchi, O., Shioi, G., Kiyonari, H., Kishimoto, T., Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo (2013) PNAS, 110, pp. 9409-9414
• Matsumoto, H., Ishibashi, Y., Ohtaki, T., Hasegawa, Y., Koyama, C., Inoue, K., Newly established murine pituitary folliculo-stellate-like cell line (TtT/GF) secretes potent pituitary glandular cell survival factors, one of which corresponds to metalloproteinase inhibitor (1993) Biochemical and Biophysical Research Communications, 194, pp. 909-915
• Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., Akira, S., Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8 (1993) PNAS, 90, pp. 10193-10197
• McFarland-Mancini, M.M., Funk, H.M., Paluch, A.M., Zhou, M., Giridhar, P.V., Mercer, C.A., Kozma, S.C., Drew, A.F., Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor (2010) Journal of Immunology, 184, pp. 7219-7228
• McInnes, I.B., Schett, G., Cytokines in the pathogenesis of rheumatoid arthritis (2007) Nature Reviews Immunology, 7, pp. 429-442
• Melmed, S., Update in pituitary disease (2008) Journal of Clinical Endocrinology and Metabolism, 93, pp. 331-338
• Melmed, S., Pathogenesis of pituitary tumors (2011) Nature Reviews Endocrinology, 7, pp. 257-266
• Melmed, S., Pituitary tumors (2015) Endocrinology Metabolism Clinics of North America, 44, pp. 1-9
• Mertens, F., Gremeaux, L., Chen, J., Fu, Q., Willems, C., Roose, H., Govaere, O., Becu-Villalobos, D., Pituitary tumors contain a side population with tumor stem cell-associated characteristics (2015) Endocrine-Related Cancer, 22, pp. 481-504
• Michaloglou, C., Vredeveld, L.C., Soengas, M.S., Denoyelle, C., Kuilman, T., van Der Horst, C.M., Majoor, D.M., Peeper, D.S., BRAFE600-associated senescence-like cell cycle arrest of human naevi (2005) Nature, 436, pp. 720-724
• Mihara, M., Hashizume, M., Yoshida, H., Suzuki, M., Shiina, M., IL-6/IL-6 receptor system and its role in physiological and pathological conditions (2012) Clinical Science, 122, pp. 143-159
• Muñoz-Espín, D., Serrano, M., Cellular senescence: From physiology to pathology (2014) Nature Reviews Molecular Cell Biology, 15, pp. 482-496
• Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Yoshizaki, K., Structure and function of a new STAT-induced STAT inhibitor (1997) Nature, 387, pp. 924-929
• Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Hirano, T., A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells (1996) EMBO Journal, 15, pp. 3651-3658
• Narita, M., Lowe, S.W., Senescence comes of age (2005) Nature Medicine, 11, pp. 920-922
• Paez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A.C., Hopfner, U., Grubler, Y., Chervin, A., Hentges, S.T., Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) PNAS, 100, pp. 1034-1039
• Paez-Pereda, M., Kuchenbauer, F., Arzt, E., Stalla, G.K., Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix (2005) Brazilian Journal of Medical and Biological Research, 38, pp. 1487-1494
• Pei, L., Melmed, S., Isolation and characterization of a pituitary tumor-transforming gene (PTTG) (1997) Molecular Endocrinology, 11, pp. 433-441
• Pereda, M.P., Goldberg, V., Chervin, A., Carrizo, G., Molina, A., Rada, J., Sauer, J., Arzt, E., Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants (1996) Molecular and Cellular Endocrinology, 124, pp. 33-42
• Pereda, M.P., Lohrer, P., Kovalovsky, D., Perez Castro, C., Goldberg, V., Losa, M., Chervin, A., Stalla, G.K., Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas (2000) Experimental and Clinical Endocrinology and Diabetes, 108, pp. 202-207
• Perez Castro, C., Nagashima, A.C., Pereda, M.P., Goldberg, V., Chervin, A., Largen, P., Renner, U., Arzt, E., The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines (2000) Endocrinology, 141, pp. 1746-1753
• Perez Castro, C., Carbia Nagashima, A., Paez Pereda, M., Goldberg, V., Chervin, A., Carrizo, G., Molina, H., Arzt, E., Effects of the gp130 cytokines ciliary neurotropic factor (CNTF) and interleukin-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of prolactin and GH secretion in normal rat anterior pituitary aggregate cultures (2001) Journal of Endocrinology, 169, pp. 539-547
• Perez-Castro, C., Renner, U., Haedo, M.R., Stalla, G.K., Arzt, E., Cellular and molecular specificity of pituitary gland physiology (2012) Physiological Reviews, 92, pp. 1-38
• Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Mullberg, J., Wolf, E., Brem, G., Rose-John, S., The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6 (1996) Journal of Experimental Medicine, 183, pp. 1399-1406
• Ray, D., Melmed, S., Pituitary cytokine and growth factor expression and action (1997) Endocrine Reviews, 18, pp. 206-228
• Reincke, M., Sbiera, S., Hayakawa, A., Theodoropoulou, M., Osswald, A., Beuschlein, F., Meitinger, T., Saeki, Y., Mutations in the deubiquitinase gene USP8 cause Cushing’s disease (2015) Nature Genetics, 47, pp. 31-38
• Renner, U., Pagotto, U., Arzt, E., Stalla, G.K., Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: A review (1996) European Journal of Endocrinology, 135, pp. 515-532
• Renner, U., Gloddek, J., Arzt, E., Inoue, K., Stalla, G.K., Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells (1997) Experimental and Clinical Endocrinology and Diabetes, 105, pp. 345-352
• Renner, U., Gloddek, J., Pereda, M.P., Arzt, E., Stalla, G.K., Regulation and role of intrapituitary IL-6 production by folliculostellate cells (1998) Domestic Animal Endocrinology, 15, pp. 353-362
• Rohleder, N., Aringer, M., Boentert, M., Role of interleukin-6 in stress, sleep, and fatigue (2012) Annals of the New York Academy of Sciences, 1261, pp. 88-96
• Rose-John, S., IL-6 trans-signaling via the soluble IL-6 receptor: Importance for the pro-inflammatory activities of IL-6 (2012) International Journal of Biological Sciences, 8, pp. 1237-1247
• Rose-John, S., Heinrich, P.C., Soluble receptors for cytokines and growth factors: Generation and biological function (1994) Biochemical Journal, 300, pp. 281-290
• Rose-John, S., Scheller, J., Elson, G., Jones, S.A., Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer (2006) Journal of Leukocyte Biology, 80, pp. 227-236
• Rossato, M., Curtale, G., Tamassia, N., Castellucci, M., Mori, L., Gasperini, S., Mariotti, B., Cassatella, M.A., IL-10-induced microRNA-187 negatively regulates TNF-alpha, IL-6, and IL-12p40 production in TLR4-stimulated monocytes (2012) PNAS, 109, pp. E3101-E3110
• Ruggeri, R.M., Villari, D., Simone, A., Scarfi, R., Attard, M., Orlandi, F., Barresi, G., Benvenga, S., Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor (2002) Journal of Endocrinological Investigation, 25, pp. 959-966
• Sapochnik, M., Haedo, M.R., Fuertes, M., Ajler, P., Carrizo, G., Cervio, A., Sevlever, G., Arzt, E., Autocrine IL-6 mediates pituitary tumor senescence (2016) Oncotarget, 8, pp. 4690-4702
• Scheithauer, B.W., Gaffey, T.A., Lloyd, R.V., Sebo, T.J., Kovacs, K.T., Horvath, E., Yapicier, O., Kuroki, T., Pathobiology of pituitary adenomas and carcinomas (2006) Neurosurgery, 59, pp. 341-353. , discussion 341-353
• Scheller, J., Rose-John, S., Interleukin-6 and its receptor: From bench to bedside (2006) Medical Microbiology and Immunology, 195, pp. 173-183
• Scheller, J., Chalaris, A., Schmidt-Arras, D., Rose-John, S., The pro-and anti-inflammatory properties of the cytokine interleukin-6 (2011) Biochimica Et Biophysica Acta, 1813, pp. 878-888
• Schett, G., Elewaut, D., McInnes, I.B., Dayer, J.M., Neurath, M.F., How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy (2013) Nature Medicine, 19, pp. 822-824
• Simonetti, S., Serrano, C., Hernandez-Losa, J., Bague, S., Orellana, R., Valverde, C., Lleonart, M.E., Ramon Y Cajal, S., Schwannomas, benign tumors with a senescent phenotype (2014) Histology and Histopathology, 29, pp. 721-730
• Spangelo, B.L., Judd, A.M., Isakson, P.C., Macleod, R.M., Interleukin-1 stimulates interleukin-6 release from rat anterior pituitary cells in vitro (1991) Endocrinology, 128, pp. 2685-2692
• Sparmann, A., Bar-Sagi, D., Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis (2004) Cancer Cell, 6, pp. 447-458
• Spooren, A., Kooijman, R., Lintermans, B., van Craenenbroeck, K., Vermeulen, L., Haegeman, G., Gerlo, S., Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes (2010) Cellular Signalling, 22, pp. 871-881
• Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Nicola, N.A., A family of cytokine-inducible inhibitors of signalling (1997) Nature, 387, pp. 917-921
• Sun, Y., Sun, J., Tomomi, T., Nieves, E., Mathewson, N., Tamaki, H., Evers, R., Reddy, P., PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6 (2013) Journal of Immunology, 190, pp. 4005-4013
• Tichomirowa, M., Theodoropoulou, M., Lohrer, P., Schaaf, L., Losa, M., Uhl, E., Lange, M., Renner, U., Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the toll-like receptor 4 (2005) Journal of Neuroendocrinology, 17, pp. 152-160
• Trivellin, G., Daly, A.F., Faucz, F.R., Yuan, B., Rostomyan, L., Larco, D.O., Schernthaner-Reiter, M.H., Caberg, J.H., Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation (2014) New England Journal of Medicine, 371, pp. 2363-2374
• Ueta, Y., Levy, A., Chowdrey, H.S., Lightman, S.L., S-100 antigen-positive folliculostellate cells are not the source of IL-6 gene expression in human pituitary adenomas (1995) Journal of Neuroendocrinology, 7, pp. 467-474
• Vajtai, I., Kappeler, A., Sahli, R., Folliculo-stellate cells of ‘true dendritic’ type are involved in the inflammatory microenvironment of tumor immunosurveillance of pituitary adenomas (2007) Diagnostic Pathology, 2, p. 20
• Vandeva, S., Jaffrain-Rea, M.L., Daly, A.F., Tichomirowa, M., Zacharieva, S., Beckers, A., The genetics of pituitary adenomas (2010) Best Practice and Research Clinical Endocrinology and Metabolism, 24, pp. 461-476
• Vankelecom, H., Gremeaux, L., Stem cells in the pituitary gland: A burgeoning field (2010) General and Comparative Endocrinology, 166, pp. 478-488
• Vankelecom, H., Carmeliet, P., van Damme, J., Billiau, A., Denef, C., Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system (1989) Neuroendocrinology, 49, pp. 102-106
• Ventura, A., Kirsch, D.G., McLaughlin, M.E., Tuveson, D.A., Grimm, J., Lintault, L., Newman, J., Jacks, T., Restoration of p53 function leads to tumour regression in vivo (2007) Nature, 445, pp. 661-665
• Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Paschke, R., Pituitary adenoma predisposition caused by germline mutations in the AIP gene (2006) Science, 312, pp. 1228-1230
• Vizioli, M.G., Santos, J., Pilotti, S., Mazzoni, M., Anania, M.C., Miranda, C., Pagliardini, S., Greco, A., Oncogenic RAS-induced senescence in human primary thyrocytes: Molecular effectors and inflammatory secretome involved (2014) Oncotarget, 5, pp. 8270-8283
• Vlotides, G., Eigler, T., Melmed, S., Pituitary tumor-transforming gene: Physiology and implications for tumorigenesis (2007) Endocrine Reviews, 28, pp. 165-186
• Wolf, J., Rose-John, S., Garbers, C., Interleukin-6 and its receptors: A highly regulated and dynamic system (2014) Cytokine, 70, pp. 11-20
• Woloski, B.M., Fuller, G.M., Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: Comparison with interleukin 1 (1985) PNAS, 82, pp. 1443-1447
• Xiang, M., Birkbak, N.J., Vafaizadeh, V., Walker, S.R., Yeh, J.E., Liu, S., Kroll, Y., Groner, B., STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-kappaB to IL-6 signaling axis and STAT3-driven cancer phenotypes (2014) Science Signaling, 7, pp. ra11
• Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., Lowe, S.W., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas (2007) Nature, 445, pp. 656-660
• Yang, X., Liang, L., Zhang, X.F., Jia, H.L., Qin, Y., Zhu, X.C., Gao, X.M., Sheng, Y.Y., MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway (2013) Hepatology, 58, pp. 158-170
• Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., Yao, Y., Targeting interleukin-6 in inflammatory autoimmune diseases and cancers (2014) Pharmacology and Therapeutics, 141, pp. 125-139
• Yasukawa, K., Hirano, T., Watanabe, Y., Muratani, K., Matsuda, T., Nakai, S., Kishimoto, T., Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene (1987) EMBO Journal, 6, pp. 2939-2945
• Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Nakahata, T., Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders (1996) PNAS, 93, pp. 407-411
• Yoshizaki, K., Nakagawa, T., Fukunaga, K., Tseng, L.T., Yamamura, Y., Kishimoto, T., Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line (1984) Journal of Immunology, 132, pp. 2948-2954
• Young, A.R., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J.F., Tavare, S., Watt, F.M., Autophagy mediates the mitotic senescence transition (2009) Genes and Development, 23, pp. 798-803
• Young, A.R., Narita, M., Narita, M., Cell senescence as both a dynamic and a static phenotype (2013) Methods in Molecular Biology, 965, pp. 1-13
• Yu, R., Melmed, S., Pathogenesis of pituitary tumors (2010) Progress in Brain Research, 182, pp. 207-227
• Yu, H., Pardoll, D., Jove, R., STATs in cancer inflammation and immunity: A leading role for STAT3 (2009) Nature Reviews Cancer, 9, pp. 798-809
• Yun, U.J., Park, S.E., Jo, Y.S., Kim, J., Shin, D.Y., DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors (2012) Cancer Letters, 323, pp. 155-160
• Zhang, X., Horwitz, G.A., Prezant, T.R., Valentini, A., Nakashima, M., Bronstein, M.D., Melmed, S., Structure, expression, and function of human pituitary tumor-transforming gene (PTTG) (1999) Molecular Endocrinology, 13, pp. 156-166
• Zhang, T., Zhao, B., Li, J., Zhang, C., Li, H., Wu, J., Zhang, S., Hui, G., Pituitary gene expression differs in D-galactose-induced cell senescence and steroid-induced prolactinomas (2015) Molecular Medicine Reports, 11, pp. 3027-3032

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------